Your browser doesn't support javascript.
loading
What do we (need to) know about the kinetic properties of nanoparticles in the body?
Hagens, Werner I; Oomen, Agnes G; de Jong, Wim H; Cassee, Flemming R; Sips, Adriënne J A M.
Affiliation
  • Hagens WI; Centre for Substances and Integrated Risk Assessment (SIR), National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, P.O. Box 1, 3720 BA Bilthoven, The Netherlands. werner.hagens@rivm.nl
Regul Toxicol Pharmacol ; 49(3): 217-29, 2007 Dec.
Article in En | MEDLINE | ID: mdl-17868963
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pharmacokinetics / Nanoparticles Limits: Animals / Humans Language: En Journal: Regul Toxicol Pharmacol Year: 2007 Document type: Article Affiliation country: Países Bajos
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Pharmacokinetics / Nanoparticles Limits: Animals / Humans Language: En Journal: Regul Toxicol Pharmacol Year: 2007 Document type: Article Affiliation country: Países Bajos